| __timestamp | Iovance Biotherapeutics, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9335772 | 205018000 |
| Thursday, January 1, 2015 | 999000 | 392709000 |
| Friday, January 1, 2016 | 978000 | 299694000 |
| Sunday, January 1, 2017 | 952000 | 397061000 |
| Monday, January 1, 2018 | 956000 | 434100000 |
| Tuesday, January 1, 2019 | 8122999 | 782200000 |
| Wednesday, January 1, 2020 | 8712000 | 1119900000 |
| Friday, January 1, 2021 | 13980000 | 2437500000 |
| Saturday, January 1, 2022 | 21135000 | 1560400000 |
| Sunday, January 1, 2023 | 10755000 | 1815800000 |
| Monday, January 1, 2024 | 1970500000 |
Unleashing the power of data
In the dynamic world of biotechnology, understanding cost structures is crucial for investors and stakeholders. This analysis delves into the cost of revenue trends for Regeneron Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc. from 2014 to 2023. Regeneron, a leader in the biotech industry, has seen its cost of revenue grow by approximately 785% over this period, peaking in 2021. In contrast, Iovance, a rising star, experienced a more modest increase of around 130% in its cost of revenue, with a notable spike in 2022. This divergence highlights Regeneron's expansive growth and Iovance's strategic scaling. The data underscores the importance of cost management in sustaining competitive advantage and profitability in the biotech sector. As the industry evolves, these insights provide a window into the financial health and strategic priorities of these two influential companies.
Vertex Pharmaceuticals Incorporated vs Iovance Biotherapeutics, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs Intra-Cellular Therapies, Inc.
Cost of Revenue Comparison: Regeneron Pharmaceuticals, Inc. vs Incyte Corporation
Cost of Revenue Trends: Regeneron Pharmaceuticals, Inc. vs Lantheus Holdings, Inc.
Regeneron Pharmaceuticals, Inc. vs Veracyte, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Perrigo Company plc's Expenses
Cost of Revenue Trends: Regeneron Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
Regeneron Pharmaceuticals, Inc. vs Xencor, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Biogen Inc. vs Iovance Biotherapeutics, Inc.
Comparing Cost of Revenue Efficiency: Insmed Incorporated vs Iovance Biotherapeutics, Inc.
Cost of Revenue Trends: Lantheus Holdings, Inc. vs Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. vs Dyne Therapeutics, Inc.: Efficiency in Cost of Revenue Explored